Endometrial Cancer

Disease State Hub

Featured

ASCO Conference Coverage
ASCO Conference Coverage
06/30/2025
Kate Young
A retrospective study presented at the American Society of Clinical Oncology 2025 annual meeting evaluated women with endometrial neuroendocrine tumors and found that adjuvant treatment with...
06/30/2025
Pop Quiz
Pop Quiz
06/26/2025
Kate Young
Endometrial cancer risk can be influenced by genetic, hormonal, and metabolic factors, and understanding which can be crucial to prevention and early detection. Do you know the risk factors for endometrial...
06/26/2025
ASCO Conference Coverage
ASCO Conference Coverage
06/05/2025
Anthony Calabro, MA
Researchers found that the combination of benmelstobart, chemotherapy, and anlotinib yields improved response and progression-free survival in patients with advanced or recurrent endometrial cancer,...
06/05/2025

Interactive Features

Pop Quiz
Pop Quiz
06/26/2025
Kate Young
Endometrial cancer risk can be influenced by genetic, hormonal, and metabolic factors, and understanding which can be crucial to prevention and early detection. Do you know the risk factors for endometrial...
06/26/2025
Slideshow
Slideshow
04/15/2025
Anthony Calabro, MA
Missed a key conference this year? We've got you covered! This curated slideshow brings together the most compelling moments, expert takeaways, and practice-changing data from the medical conferences you...
04/15/2025
Pop Quiz
Pop Quiz
03/25/2025
Anthony Calabro, MA
How current is your knowledge on endometrial cancer? Take this quiz series and see if you pass the test!
03/25/2025
Pop Quiz
Pop Quiz
03/17/2025
Miranda Manier, BA
Immunotherapy is improving endometrial cancer care—but why does it work best for certain patients? Test your knowledge in our quick quiz!
03/17/2025
Pop Quiz
Pop Quiz
02/24/2025
Miranda Manier, BA
A recent clinical trial on adjuvant therapy for endometrial cancer investigated the impact of pembrolizumab on disease-free survival. But which patient population saw the most significant benefit? Test your...
02/24/2025

Clinical Insights

Video
Video
02/18/2025
Brian M. Slomovitz, MD
In this video, Brian M. Slomovitz, MD, discusses his recent study demonstrating a significant improvement in disease-free survival with pembrolizumab in patients with dMMR endometrial cancer. He explains...
02/18/2025
Conference Coverage
Conference Coverage
08/28/2024

Anna Jo Smith, MD, MPH, MSc

Anna Jo Smith, MD, MPH, MSc
In this video, Anna Jo Smith, MD, MPH, MSc, discusses the use of two FDA-approved immunotherapy treatments for endometrial cancer in patients. She talks about health care disparities surrounding the...
08/28/2024
Expert Q&A
Stephanie Blank, MD
Expert Q&A
06/04/2024
Stephanie Blank, MD, answers questions about the session she hosted at The Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women's Cancer titled “The Future is Now: Determining the Fate of...
06/04/2024
conference coverage
conference coverage
03/31/2024

Kari E. Hacker, MD, PhD

Kari E. Hacker, MD, PhD
In this video, Kari E. Hacker, MD, PhD, discusses the results of her team's study examining the rate of HER2-expression among patients with endometrial cancer, as well as the eligibility of these patient...
03/31/2024
Conference Coverage
Conference Coverage
04/11/2023
In this video, Stephanie V. Blank, MD, and Warner K. Huh, MD, discuss the evolving role of the gynecologic oncologist, including the use of chemotherapy, benign surgery, and the management of patients with...
04/11/2023